<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-06-07 14:09:04Medicine Health Clinical medicine Rare diseases Angiology Lymphangioleiomyomatosis Benign neoplasms Signal transduction Tuberous sclerosis Angiomyolipoma Sirolimus Mechanistic target of rapamycin |
Add to Reading List |
Microsoft Word - AJP Jul16 PR Yue FINAL.docx | DOCX DocumentDocID: 1wwhs - View Document |
| DOCX DocumentDocID: 1wv76 - View Document |
| PDF DocumentDocID: 1w4hN - View Document |
| -Application for Renewal of RDMM Catalyst Grants This application is to be used by the Network’s Scientific Advisory Committee (SAC) to determine as to whether to provide an additional year of funding ($DocID: 1vceh - View Document |
| MULTISYSTEMIC RARE DISEASESDocID: 1v3AN - View Document |